Aileron management will be joined by pulmonary care medicine experts including:
Fernando J. Martinez , M.D., M.S., Chief of the Pulmonary and Critical Care Medicine Division at Weill Cornell MedicineTejaswini Kulkarni , M.D., M.P.H., Associate Professor of Pulmonology, Allergy and Critical Care Medicine and Director of the Interstitial Lung Disease Program atUniversity of Alabama at Birmingham Medicine- Andreas Günther, M.D., Senior Physician of Pulmonology and Intensive Care Medicine and Chief Physician of Pulmonology and Internal Intensive Care Medicine at Agaplesion Evang.
Central Hesse Hospital ; Professor of Interstitial and Rare Lung Diseases atJustus Liebig University
The event will include a panel discussion of emerging therapies including LTI-03, Aileron’s novel Caveolin-1-related peptide with a dual mechanism targeting alveolar epithelial cell survival and inhibition of profibrotic signaling, followed by a question-and-answer panel with the physicians.
To access the event, please dial +1 646-876-9923 (domestic) or +44 208-080-6591 (international) and reference webinar ID: 953 9620 1729 and passcode: 554257 when prompted by the operator. A live webcast of the event can be accessed at https://investors.aileronrx.com/events-presentations/investor-events. A replay of the webcast will be available following the completion of the event.
About
Investor Relations & Media Contact:
aileron@argotpartners.com
212-600-1902
Source:
2024 GlobeNewswire, Inc., source